|
IGF2BP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.01809999991853E-07 |
| Normal-vs-Stage3 |
1.7237000715653E-10 |
| Normal-vs-Stage4 |
4.527400E-01 |
| Stage1-vs-Stage2 |
3.339800E-01 |
| Stage1-vs-Stage3 |
4.424400E-01 |
| Stage1-vs-Stage4 |
5.003900E-04 |
| Stage2-vs-Stage3 |
8.378200E-01 |
| Stage2-vs-Stage4 |
1.031940E-02 |
| Stage3-vs-Stage4 |
4.359700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.077100E-03 |
| Normal-vs-Asian |
4.329400E-01 |
| Caucasian-vs-AfricanAmerican |
4.783400E-01 |
| Caucasian-vs-Asian |
1.535950E-01 |
| AfricanAmerican-vs-Asian |
1.965390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62825308791525E-12 |
| Normal-vs-Female |
7.79964981489911E-12 |
| Male-vs-Female |
7.556600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.196230E-01 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
7.01130264957328E-11 |
| Normal-vs-Age(81-100Yrs) |
1.60910000002179E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.077000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.487400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.267550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.074200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.260800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.938200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.62447832963153E-12 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
1.34336985979644E-14 |
| Normal-vs-Grade 4 |
8.445000E-01 |
| Grade 1-vs-Grade 2 |
7.26859999966578E-07 |
| Grade 1-vs-Grade 3 |
1.14490000002743E-06 |
| Grade 1-vs-Grade 4 |
1.64844999999136E-05 |
| Grade 2-vs-Grade 3 |
1.431580E-01 |
| Grade 2-vs-Grade 4 |
5.800000E-04 |
| Grade 3-vs-Grade 4 |
3.878800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.658800E-03 |
| ccA subtype-vs-ccB subtype |
1.5036000222679E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63602464908763E-12 |
| Normal-vs-N1 |
4.152600E-01 |
| N0-vs-N1 |
4.895900E-02 |
|
|
